{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:45:41Z","timestamp":1786135541864,"version":"build-2736575974"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1681\/asn.2014030280","type":"journal-article","created":{"date-parts":[[2015,4,8]],"date-time":"2015-04-08T23:37:02Z","timestamp":1428536222000},"page":"3045-3059","source":"Crossref","is-referenced-by-count":34,"title":["Reduced Renal Methylarginine Metabolism Protects against Progressive Kidney Damage"],"prefix":"10.1681","volume":"26","author":[{"given":"James A.P.","family":"Tomlinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Caplin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Boruc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Bruce-Cobbold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Cutillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Dormann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Faull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca C.","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Khadayate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria R.","family":"Mas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothea D.","family":"Nitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill T.","family":"Norman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"Wilcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Leiper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20-20230208","doi-asserted-by":"crossref","first-page":"iii32","DOI":"10.1093\/ndt\/gfs113","article-title":"The impact of CKD identification in large countries: the burden of illness.","volume":"27","author":"Jha","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R3-20-20230208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MNH.0b013e32834d54ca","article-title":"Nitric oxide synthase derangements and hypertension in kidney disease.","volume":"21","author":"Baylis","year":"2012","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R4-20-20230208","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0031-6997(25)06663-3","article-title":"Nitric oxide: Physiology, pathophysiology, and pharmacology.","volume":"43","author":"Moncada","year":"1991","journal-title":"Pharmacol Rev"},{"key":"R5-20-20230208","first-page":"2892","article-title":"Alanine-glyoxylate aminotransferase-2 metabolizes endogenous methylarginines, regulates NO, and controls blood pressure. Arterioscler Thromb Vasc","volume":"32","author":"Caplin","year":"2012","journal-title":"Biol"},{"key":"R6-20-20230208","first-page":"1343","article-title":"Endogenous nitric oxide synthase inhibitors in the biology of disease: Markers, mediators, and regulators? Arterioscler Thromb Vasc","volume":"32","author":"Caplin","year":"2012","journal-title":"Biol"},{"key":"R7-20-20230208","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2337\/db06-1772","article-title":"Expression of NG,NG-dimethylarginine dimethylaminohydrolase and protein arginine N-methyltransferase isoforms in diabetic rat kidney: Effects of angiotensin II receptor blockers.","volume":"57","author":"Onozato","year":"2008","journal-title":"Diabetes"},{"key":"R8-20-20230208","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1748-1716.2006.01582.x","article-title":"Nitric oxide in the kidney: Functions and regulation of synthesis.","volume":"187","author":"Mount","year":"2006","journal-title":"Acta Physiol (Oxf"},{"key":"R9-20-20230208","doi-asserted-by":"crossref","first-page":"74S","DOI":"10.1016\/S0895-7061(01)02073-8","article-title":"Nitric oxide in the control of renal hemodynamics and excretory function.","volume":"14","author":"Majid","year":"2001","journal-title":"Am J Hypertens"},{"key":"R10-20-20230208","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1161\/HYPERTENSIONAHA.110.159301","article-title":"Superoxide dismutase 1 limits renal microvascular remodeling and attenuates arteriole and blood pressure responses to angiotensin II via modulation of nitric oxide bioavailability.","volume":"56","author":"Carlstr\u00f6m","year":"2010","journal-title":"Hypertension"},{"key":"R11-20-20230208","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00041552-199807000-00016","article-title":"Role of macula densa NOS in tubuloglomerular feedback.","volume":"7","author":"Wilcox","year":"1998","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R12-20-20230208","doi-asserted-by":"crossref","first-page":"F777","DOI":"10.1152\/ajprenal.00334.2001","article-title":"Role of nitric oxide in the regulation of nephron transport.","volume":"282","author":"Ortiz","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"R13-20-20230208","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/ki.1997.490","article-title":"Colocalization of demethylating enzymes and NOS and functional effects of methylarginines in rat kidney.","volume":"52","author":"Tojo","year":"1997","journal-title":"Kidney Int"},{"key":"R14-20-20230208","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1093\/ndt\/17.11.1999","article-title":"Net renal extraction of asymmetrical (ADMA) and symmetrical (SDMA) dimethylarginine in fasting humans.","volume":"17","author":"Nijveldt","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"R15-20-20230208","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0140-6736(92)90865-Z","article-title":"Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure.","volume":"339","author":"Vallance","year":"1992","journal-title":"Lancet"},{"key":"R16-20-20230208","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1161\/CIRCULATIONAHA.108.838268","article-title":"Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community.","volume":"119","author":"B\u00f6ger","year":"2009","journal-title":"Circulation"},{"key":"R17-20-20230208","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ahj.2006.06.005","article-title":"Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study.","volume":"152","author":"Schulze","year":"2006","journal-title":"Am Heart J"},{"key":"R18-20-20230208","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(01)07217-8","article-title":"Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.","volume":"358","author":"Zoccali","year":"2001","journal-title":"Lancet"},{"key":"R19-20-20230208","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.2215\/CJN.06671208","article-title":"Asymmetric dimethylarginine and mortality in stages 3 to 4 chronic kidney disease.","volume":"4","author":"Young","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R20-20-20230208","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1681\/ASN.2005020179","article-title":"Asymmetric dimethylarginine and progression of chronic kidney disease: The mild to moderate kidney disease study.","volume":"16","author":"Fliser","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R21-20-20230208","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/ki.2009.463","article-title":"Circulating methylarginine levels and the decline in renal function in patients with chronic kidney disease are modulated by DDAH1 polymorphisms.","volume":"77","author":"Caplin","year":"2010","journal-title":"Kidney Int"},{"key":"R22-20-20230208","doi-asserted-by":"crossref","first-page":"F1481","DOI":"10.1152\/ajprenal.00064.2008","article-title":"An androgen-inducible proximal tubule-specific Cre recombinase transgenic model.","volume":"294","author":"Li","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"R23-20-20230208","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nm1543","article-title":"Disruption of methylarginine metabolism impairs vascular homeostasis.","volume":"13","author":"Leiper","year":"2007","journal-title":"Nat Med"},{"key":"R24-20-20230208","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1159\/000322106","article-title":"Chronic nitric oxide deficiency and progression of kidney disease after renal mass reduction in the C57Bl6 mouse.","volume":"32","author":"Muller","year":"2010","journal-title":"Am J Nephrol"},{"key":"R25-20-20230208","doi-asserted-by":"crossref","first-page":"F1060","DOI":"10.1152\/ajprenal.2000.279.6.F1060","article-title":"Mechanisms of albuminuria in the chronic nitric oxide inhibition model.","volume":"279","author":"Arcos","year":"2000","journal-title":"Am J Physiol Renal Physiol"},{"key":"R26-20-20230208","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1161\/01.CIR.0000029749.16101.44","article-title":"Long-term treatment with N(omega)-nitro-L-arginine methyl ester causes arteriosclerotic coronary lesions in endothelial nitric oxide synthase-deficient mice.","volume":"106","author":"Suda","year":"2002","journal-title":"Circulation"},{"key":"R27-20-20230208","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1681\/ASN.2005010076","article-title":"Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: A competing risks modeling approach.","volume":"16","author":"Ravani","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R28-20-20230208","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/path.2769","article-title":"Asymmetric dimethylarginine (ADMA) induces chronic kidney disease through a mechanism involving collagen and TGF-\u03b21 synthesis.","volume":"223","author":"Mihout","year":"2011","journal-title":"J Pathol"},{"key":"R29-20-20230208","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1681\/ASN.2006070696","article-title":"Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease.","volume":"18","author":"Matsumoto","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R30-20-20230208","doi-asserted-by":"crossref","first-page":"H1058","DOI":"10.1152\/ajpheart.01103.2007","article-title":"Role of asymmetric dimethylarginine for angiotensin II-induced target organ damage in mice.","volume":"294","author":"Jacobi","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R31-20-20230208","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/jor.20060","article-title":"Nitric oxide enhances collagen synthesis in cultured human tendon cells.","volume":"24","author":"Xia","year":"2006","journal-title":"J Orthop Res"},{"key":"R32-20-20230208","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1006\/bbrc.1998.8681","article-title":"Enhanced collagen accumulation following direct transfection of the inducible nitric oxide synthase gene in cutaneous wounds.","volume":"246","author":"Thornton","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"R33-20-20230208","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1067\/msy.2000.107372","article-title":"Supplemental dietary arginine enhances wound healing in normal but not inducible nitric oxide synthase knockout mice.","volume":"128","author":"Shi","year":"2000","journal-title":"Surgery"},{"key":"R34-20-20230208","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pneurobio.2005.06.001","article-title":"The physiology and pathophysiology of nitric oxide in the brain.","volume":"76","author":"Guix","year":"2005","journal-title":"Prog Neurobiol"},{"key":"R35-20-20230208","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1172\/JCI2132","article-title":"Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice. Role of endothelin.","volume":"101","author":"Chatziantoniou","year":"1998","journal-title":"J Clin Invest"},{"key":"R36-20-20230208","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1046\/j.1523-1755.1999.00462.x","article-title":"L-Arginine supplementation increases mesangial cell injury and subsequent tissue fibrosis in experimental glomerulonephritis.","volume":"55","author":"Peters","year":"1999","journal-title":"Kidney Int"},{"key":"R38-20-20230208","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1046\/j.1523-1755.2003.00881.x","article-title":"L-arginine supplementation accelerates renal fibrosis and shortens life span in experimental lupus nephritis.","volume":"63","author":"Peters","year":"2003","journal-title":"Kidney Int"},{"key":"R39-20-20230208","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1084\/jem.179.2.651","article-title":"The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: Increased nitric oxide production and nitric oxide synthase expression in MRL-lpr\/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine.","volume":"179","author":"Weinberg","year":"1994","journal-title":"J Exp Med"},{"key":"R40-20-20230208","doi-asserted-by":"crossref","first-page":"87ra53","DOI":"10.1126\/scitranslmed.3001725","article-title":"The role of dimethylarginine dimethylaminohydrolase in idiopathic pulmonary fibrosis.","volume":"3","author":"Pullamsetti","year":"2011","journal-title":"Sci Transl Med"},{"key":"R41-20-20230208","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/BF00272616","article-title":"Tamm-Horsfall protein-mRNA synthesis is localized to the thick ascending limb of Henle\u2019s loop in rat kidney.","volume":"94","author":"Bachmann","year":"1990","journal-title":"Histochemistry"},{"key":"R42-20-20230208","doi-asserted-by":"crossref","first-page":"C1088","DOI":"10.1152\/ajpcell.00523.2007","article-title":"Nitric oxide facilitates NFAT-dependent transcription in mouse myotubes.","volume":"294","author":"Drenning","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"key":"R43-20-20230208","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0024-3205(97)01172-7","article-title":"Nitric oxide inhibits Oct-1 DNA binding activity in cultured vascular smooth muscle cells.","volume":"62","author":"Liu","year":"1998","journal-title":"Life Sci"},{"key":"R44-20-20230208","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1023\/A:1022911124946","article-title":"Kidney-specific activity of the bovine uromodulin promoter.","volume":"12","author":"Kim","year":"2003","journal-title":"Transgenic Res"},{"key":"R45-20-20230208","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ki.2011.134","article-title":"The rediscovery of uromodulin (Tamm-Horsfall protein): From tubulointerstitial nephropathy to chronic kidney disease.","volume":"80","author":"Rampoldi","year":"2011","journal-title":"Kidney Int"},{"key":"R46-20-20230208","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1038\/nm.3384","article-title":"Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression.","volume":"19","author":"Trudu","year":"2013","journal-title":"Nat Med"},{"key":"R47-20-20230208","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/ncomms2186","article-title":"Supporting conditional mouse mutagenesis with a comprehensive cre characterization resource.","volume":"3","author":"Heffner","year":"2012","journal-title":"Nat Commun"},{"key":"R48-20-20230208","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cardfail.2006.03.002","article-title":"Dilated cardiomyopathy resulting from high-level myocardial expression of Cre-recombinase.","volume":"12","author":"Buerger","year":"2006","journal-title":"J Card Fail"},{"key":"R49-20-20230208","doi-asserted-by":"crossref","first-page":"9593","DOI":"10.1523\/JNEUROSCI.2815-06.2006","article-title":"High levels of Cre expression in neuronal progenitors cause defects in brain development leading to microencephaly and hydrocephaly.","volume":"26","author":"Forni","year":"2006","journal-title":"J Neurosci"},{"key":"R50-20-20230208","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/dvg.20353","article-title":"Cre activity causes widespread apoptosis and lethal anemia during embryonic development.","volume":"45","author":"Naiche","year":"2007","journal-title":"Genesis"},{"key":"R51-20-20230208","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1111\/j.1523-1755.2004.00970.x","article-title":"Quantitative amino acid and proteomic analysis: Very low excretion of polypeptides >750 Da in normal urine.","volume":"66","author":"Norden","year":"2004","journal-title":"Kidney Int"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201512000-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:45:25Z","timestamp":1786131925000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201512000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":49,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2014030280","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}